MTOR and Alzheimer disease: In this article, we will lay down the current evidence proposing the involvement of important pathways, participating in many of the above lifelong processes in the brain, i.e., the wingless-INT (Wnt), and the mammalian target of rapamycin (mTOR) (Wnt/mTOR) pathway, as a common link between ADHD and AD, and a target for a drug that can therefore act therapeutically in both diseases (Kovacs et al., 2014; Lee, 2015; Noelanders and Vleminckx, 2017; Palomer et al., 2019; Marchetti et al., 2020; Ishikawa and Ishikawa, 2022).